Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities (VOYAGER PAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02504216
Recruitment Status : Active, not recruiting
First Posted : July 21, 2015
Last Update Posted : October 10, 2019
Sponsor:
Collaborators:
Janssen Research & Development, LLC
Colorado Prevention Center
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 22, 2019
Estimated Study Completion Date : January 7, 2020